Anti-atherosclerosis or No Anti-atherosclerosis: That is the miR-33 question

doi:10.1161/ATVBAHA.112.301021

Editorial

. 2013 Mar;33(3):447-8.

doi: 10.1161/ATVBAHA.112.301021.

Anti-atherosclerosis or No Anti-atherosclerosis: That is the miR-33 question

Anders M Näär

PMID: 23407174
PMCID: PMC3880779
DOI: 10.1161/ATVBAHA.112.301021

Editorial

Anti-atherosclerosis or No Anti-atherosclerosis: That is the miR-33 question

Anders M Näär. Arterioscler Thromb Vasc Biol. 2013 Mar.

. 2013 Mar;33(3):447-8.

doi: 10.1161/ATVBAHA.112.301021.

Author

Anders M Näär

PMID: 23407174
PMCID: PMC3880779
DOI: 10.1161/ATVBAHA.112.301021

No abstract available

PubMed Disclaimer

Comment on

Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice.
Marquart TJ, Wu J, Lusis AJ, Baldán Á. Marquart TJ, et al. Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):455-8. doi: 10.1161/ATVBAHA.112.300639. Epub 2013 Jan 3. Arterioscler Thromb Vasc Biol. 2013. PMID: 23288159 Free PMC article.

Cited by

Fibroblast growth factor 21 potentially inhibits microRNA-33 expression to affect macrophage actions.
Guo Y, Luo F, Yi Y, Xu D. Guo Y, et al. Lipids Health Dis. 2016 Dec 1;15(1):208. doi: 10.1186/s12944-016-0381-6. Lipids Health Dis. 2016. PMID: 27905947 Free PMC article. Review.
The Impact of MiR-33a-5p Inhibition in Pro-Inflammatory Endothelial Cells.
Huang K, Pitman M, Oladosu O, Echesabal-Chen J, Vojtech L, Esobi I, Larsen J, Jo H, Stamatikos A. Huang K, et al. Diseases. 2023 Jun 24;11(3):88. doi: 10.3390/diseases11030088. Diseases. 2023. PMID: 37489440 Free PMC article.
Soy and fish as features of the Japanese diet and cardiovascular disease risks.
Yamori Y, Sagara M, Arai Y, Kobayashi H, Kishimoto K, Matsuno I, Mori H, Mori M. Yamori Y, et al. PLoS One. 2017 Apr 21;12(4):e0176039. doi: 10.1371/journal.pone.0176039. eCollection 2017. PLoS One. 2017. PMID: 28430815 Free PMC article.
MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.
Horie T, Nishino T, Baba O, Kuwabara Y, Nakao T, Nishiga M, Usami S, Izuhara M, Sowa N, Yahagi N, Shimano H, Matsumura S, Inoue K, Marusawa H, Nakamura T, Hasegawa K, Kume N, Yokode M, Kita T, Kimura T, Ono K. Horie T, et al. Nat Commun. 2013;4:2883. doi: 10.1038/ncomms3883. Nat Commun. 2013. PMID: 24300912 Free PMC article.
Inhibition of miR-33a-5p in Macrophage-like Cells In Vitro Promotes apoAI-Mediated Cholesterol Efflux.
Oladosu O, Chin E, Barksdale C, Powell RR, Bruce T, Stamatikos A. Oladosu O, et al. Pathophysiology. 2024 Feb 28;31(1):117-126. doi: 10.3390/pathophysiology31010009. Pathophysiology. 2024. PMID: 38535619 Free PMC article.

See all "Cited by" articles

References

1. Walker AK, Näär AM. SREBPs: regulators of cholesterol/lipids as therapeutic targets in metabolic disorders, cancers and viral diseases. Clin Lipidol. 2012;7:27–36.
1. Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, Näär AM. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science. 2010;328:1566–1569. - PMC - PubMed
1. Rayner KJ, Suárez Y, Dávalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fernández-Hernando C. MiR-33 contributes to the regulation of cholesterol homeostasis. Science. 2010;328:1570–1573. - PMC - PubMed
1. Marquart TJ, Allen RM, Ory DS, Baldán A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA. 2010;107:12228–12232. - PMC - PubMed
1. Horie T, Ono K, Horiguchi M, Nishi H, Nakamura T, Nagao K, Kinoshita M, Kuwabara Y, Marusawa H, Iwanaga Y, Hasegawa K, Yokode M, Kimura T, Kita T. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci USA. 2010;107:17321–17326. - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

Grants and funding

R01 DK094184/DK/NIDDK NIH HHS/United States

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] Walker AK, Näär AM. SREBPs: regulators of cholesterol/lipids as therapeutic targets in metabolic disorders, cancers and viral diseases. Clin Lipidol. 2012;7:27–36.

[2] Walker AK, Näär AM. SREBPs: regulators of cholesterol/lipids as therapeutic targets in metabolic disorders, cancers and viral diseases. Clin Lipidol. 2012;7:27–36.

[3] Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, Näär AM. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science. 2010;328:1566–1569. - PMC - PubMed

[4] Najafi-Shoushtari SH, Kristo F, Li Y, Shioda T, Cohen DE, Gerszten RE, Näär AM. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science. 2010;328:1566–1569. - PMC - PubMed

[5] Rayner KJ, Suárez Y, Dávalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fernández-Hernando C. MiR-33 contributes to the regulation of cholesterol homeostasis. Science. 2010;328:1570–1573. - PMC - PubMed

[6] Rayner KJ, Suárez Y, Dávalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fernández-Hernando C. MiR-33 contributes to the regulation of cholesterol homeostasis. Science. 2010;328:1570–1573. - PMC - PubMed

[7] Marquart TJ, Allen RM, Ory DS, Baldán A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA. 2010;107:12228–12232. - PMC - PubMed

[8] Marquart TJ, Allen RM, Ory DS, Baldán A. miR-33 links SREBP-2 induction to repression of sterol transporters. Proc Natl Acad Sci USA. 2010;107:12228–12232. - PMC - PubMed

[9] Horie T, Ono K, Horiguchi M, Nishi H, Nakamura T, Nagao K, Kinoshita M, Kuwabara Y, Marusawa H, Iwanaga Y, Hasegawa K, Yokode M, Kimura T, Kita T. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci USA. 2010;107:17321–17326. - PMC - PubMed

[10] Horie T, Ono K, Horiguchi M, Nishi H, Nakamura T, Nagao K, Kinoshita M, Kuwabara Y, Marusawa H, Iwanaga Y, Hasegawa K, Yokode M, Kimura T, Kita T. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo. Proc Natl Acad Sci USA. 2010;107:17321–17326. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Anti-atherosclerosis or No Anti-atherosclerosis: That is the miR-33 question

Anti-atherosclerosis or No Anti-atherosclerosis: That is the miR-33 question

Author

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical